Myrsini Ioakeim-Ioannidou
Overview
Explore the profile of Myrsini Ioakeim-Ioannidou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Power P, Liu K, Chi S, Wright K, Marcus K, Haas-Kogan D, et al.
Pediatr Blood Cancer
. 2025 Mar;
:e31628.
PMID: 40038880
Background: Germinoma is the most common intracranial germ cell tumor (IGCT) in children and young adults. Treatment with 24 Gy craniospinal irradiation (CSI) with boost to 40 Gy alone results...
2.
Ioakeim-Ioannidou M, Goldberg S, Urell T, Tejada A, Nielsen G, Hung Y, et al.
Int J Radiat Oncol Biol Phys
. 2024 Sep;
121(2):403-413.
PMID: 39303998
Purpose: The literature on skull base chondrosarcoma (CHS) is scarce. We report outcomes for pediatric and young patients ≤22 years with base of skull CHSs treated with proton-based radiation therapy...
3.
Liu K, Shaaban S, Chen J, Bagatell R, Lerman B, Catalano P, et al.
Radiother Oncol
. 2024 Jun;
198:110384.
PMID: 38880415
Background: Prognosis for patients with high-risk neuroblastoma (HR-NBL) is guarded despite aggressive therapy, and few studies have characterized outcomes after radiotherapy in relation to radiation treatment fields. Methods: Multi-institutional retrospective...
4.
Ioakeim-Ioannidou M, Rose M, Chen Y, MacDonald S
Semin Radiat Oncol
. 2024 Mar;
34(2):207-217.
PMID: 38508785
The unique physical and biological characteristics of proton and carbon ions allow for improved sparing of normal tissues, decreased integral dose to the body, and increased biological effect through high...
5.
Ioakeim-Ioannidou M, Daartz J, Erfani P, Urell T, Lalonde A, Berv J, et al.
Pediatr Blood Cancer
. 2024 Feb;
71(5):e30927.
PMID: 38421306
Background: Unusual olfactory perception, often referred to as "phantosmia" or "cacosmia" has been reported during brain radiotherapy (RT), but is infrequent and does not typically interfere with the ability to...
6.
He L, Zhong C, Chang H, Inman J, Celniker S, Ioakeim-Ioannidou M, et al.
Cell Genom
. 2023 Nov;
3(11):100422.
PMID: 38020972
Hematologic toxicity is a common side effect of multimodal cancer therapy. Nearly all animal studies investigating the causes of radiotherapy-induced hematologic toxicity use inbred strains with limited genetic diversity and...
7.
Ioakeim-Ioannidou M, Niemierko A, Kim D, Tejada A, Urell T, Leahy S, et al.
Neuro Oncol
. 2023 Apr;
25(9):1686-1697.
PMID: 37029730
Background: Data on clinical outcomes for base of skull (BOS) chordomas in the pediatric population is limited. We report patient outcomes after surgery and proton radiotherapy (PRT). Methods: Pediatric patients...
8.
Ioakeim-Ioannidou M, Tejada A, Urell T, Depauw N, Kooy H, Adams J, et al.
Pract Radiat Oncol
. 2023 Jan;
13(4):e319-e324.
PMID: 36641091
Radiation vasculopathy is a well-recognized late complication of radiation therapy. We present a case of a stroke 29 years after high-dose proton radiation therapy for skull-base chordoma due to occlusion...
9.
Ioakeim-Ioannidou M, Giantsoudi D, Niemierko A, Sethi R, Kim D, Yock T, et al.
Int J Radiat Oncol Biol Phys
. 2022 Sep;
115(3):572-580.
PMID: 36055432
Purpose: It is of great interest to physicians and patients/patients' families to be able to predict the amount of growth decrement after craniospinal irradiation (CSI). Little data exist on the...
10.
Franco J, Liu K, Ioakeim-Ioannidou M, Davila J, Chen Y, Kim I, et al.
Pediatr Blood Cancer
. 2022 Aug;
69(12):e29925.
PMID: 35989464
Management of pediatric choroidal hemangioma complicated by large exudative retinal detachment can be challenging, with few options available. Limited data have been published on outcomes following proton radiotherapy (PRT) for...